Assessment of Health Care Exposures and Outcomes in Adult Patients With Sepsis and Septic Shock.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
01 07 2020
Historique:
entrez: 8 7 2020
pubmed: 8 7 2020
medline: 29 12 2020
Statut: epublish

Résumé

Current information on the characteristics of patients who develop sepsis may help in identifying opportunities to improve outcomes. Most recent studies of sepsis epidemiology have focused on changes in incidence or have used administrative data sets that provided limited patient-level data. To describe sepsis epidemiology in adults. This retrospective cohort study reviewed the medical records, death certificates, and hospital discharge data of adult patients with sepsis or septic shock who were discharged from the hospital between October 1, 2014, and September 30, 2015. The convenience sample was obtained from hospitals in the Centers for Disease Control and Prevention Emerging Infections Program in 10 states (California, Colorado, Connecticut, Georgia, Maryland, Minnesota, New Mexico, New York, Oregon, and Tennessee). Patients 18 years and older with discharge diagnosis codes for severe sepsis or septic shock were randomly selected. Data were analyzed between May 1, 2018, and January 31, 2019. The population's demographic characteristics, health care exposures, and sepsis-associated infections and pathogens were described, and risk factors for death within 30 days after sepsis diagnosis were assessed. Among 1078 adult patients with sepsis (569 men [52.8%]; median age, 64 years [interquartile range, 53-75 years]), 973 patients (90.3%) were classified as having community-onset sepsis (ie, sepsis diagnosed within 3 days of hospital admission). In total, 654 patients (60.7%) had health care exposures before their hospital admission for sepsis; 260 patients (24.1%) had outpatient encounters in the 7 days before admission, and 447 patients (41.5%) received medical treatment, including antimicrobial drugs, chemotherapy, wound care, dialysis, or surgery, in the 30 days before admission. A pathogen associated with sepsis was found in 613 patients (56.9%); the most common pathogens identified were Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae, and Clostridioides difficile. After controlling for other factors, an association was found between underlying comorbidities, such as cirrhosis (odds ratio, 3.59; 95% CI, 2.03-6.32), immunosuppression (odds ratio, 2.52; 95% CI, 1.81-3.52), vascular disease (odds ratio, 1.54; 95% CI, 1.10-2.15), and 30-day mortality. Most adults experienced sepsis onset outside of the hospital and had recent encounters with the health care system. A sepsis-associated pathogen was identified in more than half of patients. Future efforts to improve sepsis outcomes may benefit from examination of health maintenance practices and recent health care exposures as potential opportunities among high-risk patients.

Identifiants

pubmed: 32633762
pii: 2767942
doi: 10.1001/jamanetworkopen.2020.6004
pmc: PMC7341174
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e206004

Références

Ann Am Thorac Soc. 2019 Jan;16(1):116-123
pubmed: 30212640
JAMA. 2018 Oct 9;320(14):1433-1434
pubmed: 30242350
MMWR Morb Mortal Wkly Rep. 2016 Aug 26;65(33):864-9
pubmed: 27559759
JAMA. 2017 Oct 3;318(13):1241-1249
pubmed: 28903154
Chest. 1992 Jun;101(6):1644-55
pubmed: 1303622
Emerg Infect Dis. 2015 Sep;21(9):1537-42
pubmed: 26291035
PLoS One. 2017 Oct 31;12(10):e0186903
pubmed: 29088258
Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12313-9
pubmed: 25136129
Crit Care Med. 2017 Mar;45(3):486-552
pubmed: 28098591
Crit Care Med. 2018 Nov;46(11):1753-1760
pubmed: 30024430
JAMA Netw Open. 2019 Feb 1;2(2):e187571
pubmed: 30768188
J Clin Invest. 2014 Oct;124(10):4212-8
pubmed: 25271726
Clin Infect Dis. 2015 Jan 1;60(1):88-95
pubmed: 25258352
Crit Care Med. 2018 Apr;46(4):513-516
pubmed: 29309371
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338

Auteurs

Katherine Fay (K)

Division of Bacterial Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia.

Mathew R P Sapiano (MRP)

Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.

Runa Gokhale (R)

Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.

Raymund Dantes (R)

Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Emory University School of Medicine, Atlanta, Georgia.

Nicola Thompson (N)

Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.

David E Katz (DE)

Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.

Susan M Ray (SM)

Emory University School of Medicine, Atlanta, Georgia.
Georgia Emerging Infections Program, Decatur.

Lucy E Wilson (LE)

Maryland Department of Health, Baltimore.

Rebecca Perlmutter (R)

Maryland Department of Health, Baltimore.

Joelle Nadle (J)

California Emerging Infections Program, Oakland.

Deborah Godine (D)

California Emerging Infections Program, Oakland.

Linda Frank (L)

California Emerging Infections Program, Oakland.

Geoff Brousseau (G)

Colorado Department of Public Health and Environment, Denver.

Helen Johnston (H)

Colorado Department of Public Health and Environment, Denver.

Wendy Bamberg (W)

Colorado Department of Public Health and Environment, Denver.

Ghinwa Dumyati (G)

New York Emerging Infections Program, University of Rochester Medical Center, Rochester.

Deborah Nelson (D)

New York Emerging Infections Program, University of Rochester Medical Center, Rochester.

Ruth Lynfield (R)

Minnesota Department of Health, St Paul.

Malini DeSilva (M)

Minnesota Department of Health, St Paul.

Marion Kainer (M)

Tennessee Department of Health, Nashville.

Alexia Zhang (A)

Oregon Health Authority, Portland.

Valerie Ocampo (V)

Oregon Health Authority, Portland.

Monika Samper (M)

Oregon Health Authority, Portland.

Rebecca Pierce (R)

Oregon Health Authority, Portland.

Lourdes Irizarry (L)

New Mexico Department of Health, Santa Fe.

Marla Sievers (M)

New Mexico Department of Health, Santa Fe.

Meghan Maloney (M)

Connecticut Emerging Infections Program, Hartford.

Anthony Fiore (A)

Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.

Shelley S Magill (SS)

Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.

Lauren Epstein (L)

Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH